Business
Paradigm (ASX:PAR) share price shoots 30% higher on FDA update
Image source: Getty Images
The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price has returned from its trading halt and is charging higher on Wednesday.
At the time of writing, the biopharmaceutical company’s shares are up 30% to $2.69.
Why is the Paradigm share price charging higher?
…
Continue Reading
-
General17 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
General23 hours agoCritically endangered orchid thrives as NSW Mid North Coast cemetery provides habitat refuge
-
Noosa News20 hours agoSanta drops in for carols
-
Business23 hours agoThe best Australian stock you’ve never heard of